Crossmark Global Holdings’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.35M | Sell |
3,461
-47
| -1% | -$19.9K | 0.02% | 558 |
|
|
2026
Q1 | $1.66M | Sell |
3,508
-224
| -6% | -$113K | 0.02% | 479 |
|
|
2025
Q4 | $1.74M | Sell |
3,732
-149
| -4% | -$69.2K | 0.03% | 462 |
|
|
2025
Q3 | $1.65M | Buy |
3,881
+1,805
| +87% | +$700K | 0.02% | 499 |
|
|
2025
Q2 | $795K | Sell |
2,076
-369
| -15% | -$133K | 0.01% | 694 |
|
|
2025
Q1 | $845K | Buy |
2,445
+44
| +2% | +$14.2K | 0.01% | 664 |
|
|
2024
Q4 | $720K | Sell |
2,401
-401
| -14% | -$140K | 0.01% | 687 |
|
|
2024
Q3 | $1.14M | Sell |
2,802
-38
| -1% | -$13.9K | 0.02% | 567 |
|
|
2024
Q2 | $913K | Buy |
2,840
+12
| +0.4% | +$3.9K | 0.02% | 612 |
|
|
2024
Q1 | $943K | Sell |
2,828
-276
| -9% | -$84.3K | 0.02% | 636 |
|
|
2023
Q4 | $840K | Sell |
3,104
-184
| -6% | -$45.5K | 0.02% | 652 |
|
|
2023
Q3 | $832K | Sell |
3,288
-68
| -2% | -$18.6K | 0.02% | 624 |
|
|
2023
Q2 | $917K | Buy |
3,356
+121
| +4% | +$33.6K | 0.02% | 615 |
|
|
2023
Q1 | $853K | Sell |
3,235
-35
| -1% | -$8.89K | 0.02% | 627 |
|
|
2022
Q4 | $785K | Sell |
3,270
-85
| -3% | -$19K | 0.02% | 630 |
|
|
2022
Q3 | $617K | Sell |
3,355
-203
| -6% | -$40.4K | 0.02% | 697 |
|
|
2022
Q2 | $597K | Sell |
3,558
-40
| -1% | -$8.59K | 0.02% | 740 |
|
|
2022
Q1 | $902K | Sell |
3,598
-50
| -1% | -$12.6K | 0.02% | 663 |
|
|
2021
Q4 | $937K | Sell |
3,648
-170
| -4% | -$41.6K | 0.02% | 652 |
|
|
2021
Q3 | $927K | Sell |
3,818
-100
| -3% | -$24.4K | 0.02% | 634 |
|
|
2021
Q2 | $810K | Sell |
3,918
-620
| -14% | -$126K | 0.02% | 683 |
|
|
2021
Q1 | $855K | Buy |
4,538
+30
| +0.7% | +$5.29K | 0.02% | 650 |
|
|
2020
Q4 | $741K | Sell |
4,508
-83
| -2% | -$12.1K | 0.02% | 678 |
|
|
2020
Q3 | $572K | Sell |
4,591
-300
| -6% | -$37.1K | 0.02% | 712 |
|
|
2020
Q2 | $475K | Buy |
4,891
+55
| +1% | +$5.72K | 0.01% | 783 |
|
|
2020
Q1 | $435K | Sell |
4,836
-176
| -4% | -$22.8K | 0.02% | 698 |
|
|
2019
Q4 | $741K | Sell |
5,012
-448
| -8% | -$60.2K | 0.02% | 650 |
|
|
2019
Q3 | $657K | Sell |
5,460
-1,100
| -17% | -$142K | 0.02% | 679 |
|
|
2019
Q2 | $887K | Sell |
6,560
-173
| -3% | -$21.9K | 0.02% | 583 |
|
|
2019
Q1 | $878K | Sell |
6,733
-390
| -5% | -$52.4K | 0.02% | 586 |
|
|
2018
Q4 | $886K | Buy |
7,123
+940
| +15% | +$126K | 0.03% | 556 |
|
|
2018
Q3 | $860K | Buy |
6,183
+500
| +9% | +$62.2K | 0.02% | 668 |
|
|
2018
Q2 | $583K | Sell |
5,683
-1,110
| -16% | -$112K | 0.02% | 854 |
|
|
2018
Q1 | $659K | Sell |
6,793
-133
| -2% | -$12.9K | 0.02% | 770 |
|
|
2017
Q4 | $608K | Sell |
6,926
-17
| -0.2% | -$1.37K | 0.01% | 859 |
|
|
2017
Q3 | $553K | Buy |
+6,943
| New | +$558K | 0.01% | 894 |
|
|
2016
Q3 | $553K | Buy |
+6,943
| New | +$532K | 0.01% | 894 |
|
Other funds holding HCA
Crossmark Global Holdings's HCA Position: Q2 2026 in Review
Crossmark Global Holdings reduced its HCA Healthcare (HCA) stake by 1.3% in Q2 2026, selling an estimated $19.9K and leaving 3,461 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #558.
Crossmark Global Holdings first reported a position in HCA in Q3 2016 and has held it in 37 quarters since. The position peaked at $1.74M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Crossmark Global Holdings held 3,461 shares of HCA Healthcare worth $1.35M as of Q2 2026.
- Crossmark Global Holdings sold 47 HCA Healthcare shares in Q2 2026, an estimated $19.9K.
- HCA Healthcare made up 0.02% of Crossmark Global Holdings's portfolio in Q2 2026, its #558 holding.
- Crossmark Global Holdings first reported a position in HCA Healthcare in Q3 2016 and has held it in 37 quarters since.
- Crossmark Global Holdings's HCA Healthcare position peaked at $1.74M in Q4 2025.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.